Dr. Robert Chilton, DO
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Years since graduation
- 54
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 23
Licensed in Texas since 1978, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
TX license F0933 (first issued 1978; active) -
Cardiovascular Disease Physician
TX license F0933 (first issued 1978; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- University of Texas Health Science Center at San Antonio (1,297 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 23
- Services billed
- 43
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 12 companies reported 100 payments worth $142,636 in total to this clinician.
| Novo Nordisk Inc | $66,290 |
|---|---|
| Lilly USA, LLC | $38,500 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28,077 |
| Corcept Therapeutics | $9,009 |
| Abbott Laboratories | $156 |
| Merck Sharp & Dohme LLC | $146 |
| Teleflex LLC | $137 |
| Biotronik Inc. | $133 |
| Compensation for services other than consulting (speaking, faculty) | $125,309 |
|---|---|
| Travel and Lodging | $12,714 |
| Food and Beverage | $2,651 |
| Consulting Fee | $1,963 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $9,224 |
| Novo Nordisk Inc Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $8,831 |
| Novo Nordisk Inc Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $8,439 |
| Novo Nordisk Inc Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $8,046 |
| Novo Nordisk Inc May 15, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $7,654 |
| Novo Nordisk Inc Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $7,261 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $5,700 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Corcept Therapeutics Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $4,050 |
All 62 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Corcept Therapeutics Dec 17, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $4,050 |
| Corcept Therapeutics Dec 2, 2025 | Travel and Lodging Korlym · Endocrinology · travel to Universal City, CA · in-kind | $257 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Nov 10, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Lilly USA, LLC Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $3,040 |
| Lilly USA, LLC Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,520 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 25, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,520 |
| Lilly USA, LLC Sep 11, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $4,175 |
| Lilly USA, LLC Aug 28, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Aug 18, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Jul 31, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Jul 25, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Jul 21, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jul 16, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,520 |
| Lilly USA, LLC Jul 10, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Jul 2, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Jun 30, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Novo Nordisk Inc Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $8,831 |
| Novo Nordisk Inc Jun 25, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $1,168 |
| Novo Nordisk Inc Jun 25, 2025 | Travel and Lodging Wegovy · Obesity · travel to Twin Oaks, MO · in-kind | $1,130 |
| Novo Nordisk Inc Jun 25, 2025 | Travel and Lodging Wegovy · Obesity · travel to Twin Oaks, MO · in-kind | $910 |
| Novo Nordisk Inc Jun 25, 2025 | Travel and Lodging Wegovy · Obesity · travel to Twin Oaks, MO · in-kind | $412 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 24, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,520 |
| Lilly USA, LLC Jun 23, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Jun 16, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Jun 9, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Jun 5, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Corcept Therapeutics Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) Korlym · Endocrinology | $4,050 |
| Novo Nordisk Inc May 15, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $7,654 |
| Novo Nordisk Inc May 15, 2025 | Travel and Lodging Wegovy · Obesity · travel to Austin, TX · in-kind | $855 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 7, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,520 |
| Boehringer Ingelheim Pharmaceuticals, Inc. May 1, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,520 |
| Lilly USA, LLC Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $5,700 |
| Novo Nordisk Inc Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $9,224 |
| Lilly USA, LLC Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Novo Nordisk Inc Apr 2, 2025 | Travel and Lodging Wegovy · Obesity · travel to Bettendorf, IA · in-kind | $879 |
| Novo Nordisk Inc Apr 2, 2025 | Travel and Lodging Wegovy · Obesity · travel to Bettendorf, IA · in-kind | $345 |
| Novo Nordisk Inc Apr 2, 2025 | Travel and Lodging Wegovy · Obesity · travel to Bettendorf, IA · in-kind | $275 |
| Lilly USA, LLC Mar 31, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Mar 24, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Lilly USA, LLC Mar 18, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Mar 17, 2025 | Travel and Lodging JARDIANCE · DIABETES · travel to Gastonia, NC · in-kind | $1,515 |
| Lilly USA, LLC Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $2,280 |
| Lilly USA, LLC Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $1,520 |
| Novo Nordisk Inc Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $8,439 |
| Novo Nordisk Inc Mar 6, 2025 | Travel and Lodging Wegovy · Obesity · travel to Tulsa, OK · in-kind | $1,474 |
| Novo Nordisk Inc Mar 6, 2025 | Travel and Lodging Wegovy · Obesity · travel to Tulsa, OK · in-kind | $612 |
| Novo Nordisk Inc Mar 6, 2025 | Travel and Lodging Wegovy · Obesity · travel to Tulsa, OK · in-kind | $209 |
| Novo Nordisk Inc Mar 4, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $8,046 |
| Novo Nordisk Inc Mar 4, 2025 | Travel and Lodging Wegovy · Obesity · travel to Pearland, TX · in-kind | $1,212 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,520 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Feb 28, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,520 |
| Novo Nordisk Inc Feb 11, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $7,261 |
| Novo Nordisk Inc Feb 11, 2025 | Travel and Lodging Wegovy · Obesity · travel to Kansas City, MO · in-kind | $1,448 |
| Novo Nordisk Inc Feb 11, 2025 | Travel and Lodging Wegovy · Obesity · travel to Kansas City, MO · in-kind | $893 |
| Novo Nordisk Inc Feb 11, 2025 | Travel and Lodging Wegovy · Obesity · travel to Kansas City, MO · in-kind | $289 |
| Novo Nordisk Inc Jan 1, 2025 | Compensation for services other than consulting (speaking, faculty) Wegovy · Obesity | $2,002 |
| Novo Nordisk Inc Jan 1, 2025 | Consulting Fee | $1,963 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.